nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—AKR1C3—uterine cancer	0.234	0.624	CbGaD
Indomethacin—CXCL8—uterine cancer	0.141	0.375	CbGaD
Indomethacin—AKR1C3—Medroxyprogesterone Acetate—uterine cancer	0.12	0.271	CbGbCtD
Indomethacin—SLC10A1—Progesterone—uterine cancer	0.0518	0.117	CbGbCtD
Indomethacin—ABCC6—Dactinomycin—uterine cancer	0.0475	0.107	CbGbCtD
Indomethacin—ABCC6—Etoposide—uterine cancer	0.0268	0.0603	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—uterine cancer	0.0243	0.0547	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—uterine cancer	0.0183	0.0412	CbGbCtD
Indomethacin—ABCC1—Progesterone—uterine cancer	0.0177	0.0398	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—uterine cancer	0.0143	0.0322	CbGbCtD
Indomethacin—ABCC1—Dactinomycin—uterine cancer	0.014	0.0315	CbGbCtD
Indomethacin—ABCC3—Etoposide—uterine cancer	0.0129	0.029	CbGbCtD
Indomethacin—ABCC1—Epirubicin—uterine cancer	0.0101	0.0228	CbGbCtD
Indomethacin—UGT1A1—Etoposide—uterine cancer	0.00962	0.0217	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—uterine cancer	0.00878	0.0198	CbGbCtD
Indomethacin—ABCC1—Etoposide—uterine cancer	0.00791	0.0178	CbGbCtD
Indomethacin—ABCC2—Carboplatin—uterine cancer	0.00697	0.0157	CbGbCtD
Indomethacin—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.00663	0.0149	CbGbCtD
Indomethacin—ABCC2—Etoposide—uterine cancer	0.00585	0.0132	CbGbCtD
Indomethacin—PTGS2—Etoposide—uterine cancer	0.00578	0.013	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—uterine cancer	0.00539	0.0121	CbGbCtD
Indomethacin—CYP2C19—Progesterone—uterine cancer	0.00528	0.0119	CbGbCtD
Indomethacin—PTGS1—Etoposide—uterine cancer	0.00488	0.011	CbGbCtD
Indomethacin—CYP2C9—Progesterone—uterine cancer	0.00439	0.00989	CbGbCtD
Indomethacin—ABCB1—Progesterone—uterine cancer	0.00426	0.0096	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—uterine cancer	0.00399	0.00899	CbGbCtD
Indomethacin—ABCB1—Dactinomycin—uterine cancer	0.00338	0.00761	CbGbCtD
Indomethacin—ABCB1—Etoposide—uterine cancer	0.00191	0.00429	CbGbCtD
Indomethacin—ABCB1—Doxorubicin—uterine cancer	0.0013	0.00293	CbGbCtD
Indomethacin—PTGR2—myometrium—uterine cancer	0.00129	0.026	CbGeAlD
Indomethacin—PTGDR2—female reproductive system—uterine cancer	0.00113	0.0228	CbGeAlD
Indomethacin—Naproxen—AKR1C3—uterine cancer	0.00107	0.556	CrCbGaD
Indomethacin—PTGR2—renal system—uterine cancer	0.00094	0.0189	CbGeAlD
Indomethacin—PTGR2—endometrium—uterine cancer	0.000909	0.0183	CbGeAlD
Indomethacin—Tolmetin—CXCL8—uterine cancer	0.000858	0.444	CrCbGaD
Indomethacin—ABCC6—Podofilox—Etoposide—uterine cancer	0.000817	0.434	CbGdCrCtD
Indomethacin—GLO1—myometrium—uterine cancer	0.000798	0.0161	CbGeAlD
Indomethacin—PPARG—artery—uterine cancer	0.000788	0.0159	CbGeAlD
Indomethacin—ABCC11—female reproductive system—uterine cancer	0.000745	0.015	CbGeAlD
Indomethacin—PLA2G2A—myometrium—uterine cancer	0.000742	0.0149	CbGeAlD
Indomethacin—CXCL8—myometrium—uterine cancer	0.000734	0.0148	CbGeAlD
Indomethacin—AKR1C3—Podofilox—Etoposide—uterine cancer	0.000714	0.379	CbGdCrCtD
Indomethacin—PTGR2—female gonad—uterine cancer	0.000685	0.0138	CbGeAlD
Indomethacin—PTGR2—vagina—uterine cancer	0.000681	0.0137	CbGeAlD
Indomethacin—ABCC11—female gonad—uterine cancer	0.000678	0.0137	CbGeAlD
Indomethacin—PTGS1—oviduct—uterine cancer	0.000636	0.0128	CbGeAlD
Indomethacin—GLO1—epithelium—uterine cancer	0.000626	0.0126	CbGeAlD
Indomethacin—GLO1—uterine cervix—uterine cancer	0.000621	0.0125	CbGeAlD
Indomethacin—GLO1—smooth muscle tissue—uterine cancer	0.000603	0.0121	CbGeAlD
Indomethacin—GLO1—decidua—uterine cancer	0.000591	0.0119	CbGeAlD
Indomethacin—PLA2G2A—epithelium—uterine cancer	0.000582	0.0117	CbGeAlD
Indomethacin—GLO1—renal system—uterine cancer	0.000581	0.0117	CbGeAlD
Indomethacin—AKR1C3—myometrium—uterine cancer	0.000575	0.0116	CbGeAlD
Indomethacin—CXCL8—uterine cervix—uterine cancer	0.000571	0.0115	CbGeAlD
Indomethacin—UGT1A9—renal system—uterine cancer	0.000564	0.0114	CbGeAlD
Indomethacin—GLO1—endometrium—uterine cancer	0.000561	0.0113	CbGeAlD
Indomethacin—PLA2G2A—smooth muscle tissue—uterine cancer	0.000561	0.0113	CbGeAlD
Indomethacin—CXCL8—smooth muscle tissue—uterine cancer	0.000555	0.0112	CbGeAlD
Indomethacin—PLA2G2A—decidua—uterine cancer	0.00055	0.0111	CbGeAlD
Indomethacin—CXCL8—decidua—uterine cancer	0.000544	0.011	CbGeAlD
Indomethacin—PPARA—epithelium—uterine cancer	0.000544	0.0109	CbGeAlD
Indomethacin—GLO1—mammalian vulva—uterine cancer	0.000543	0.0109	CbGeAlD
Indomethacin—PLA2G2A—renal system—uterine cancer	0.00054	0.0109	CbGeAlD
Indomethacin—ABCC6—renal system—uterine cancer	0.000534	0.0108	CbGeAlD
Indomethacin—PPARA—smooth muscle tissue—uterine cancer	0.000524	0.0105	CbGeAlD
Indomethacin—PLA2G2A—endometrium—uterine cancer	0.000522	0.0105	CbGeAlD
Indomethacin—GLO1—uterus—uterine cancer	0.000517	0.0104	CbGeAlD
Indomethacin—CXCL8—endometrium—uterine cancer	0.000517	0.0104	CbGeAlD
Indomethacin—PLA2G2A—mammalian vulva—uterine cancer	0.000505	0.0102	CbGeAlD
Indomethacin—PPARA—renal system—uterine cancer	0.000504	0.0102	CbGeAlD
Indomethacin—SLC10A1—renal system—uterine cancer	0.000485	0.00977	CbGeAlD
Indomethacin—GLO1—female reproductive system—uterine cancer	0.000465	0.00937	CbGeAlD
Indomethacin—UGT2B7—renal system—uterine cancer	0.000454	0.00915	CbGeAlD
Indomethacin—AKR1C3—uterine cervix—uterine cancer	0.000448	0.00902	CbGeAlD
Indomethacin—SLC22A11—renal system—uterine cancer	0.000443	0.00892	CbGeAlD
Indomethacin—PTGR2—lymph node—uterine cancer	0.00044	0.00887	CbGeAlD
Indomethacin—AKR1C3—smooth muscle tissue—uterine cancer	0.000435	0.00876	CbGeAlD
Indomethacin—PLA2G2A—female reproductive system—uterine cancer	0.000432	0.00871	CbGeAlD
Indomethacin—SLC22A7—renal system—uterine cancer	0.000432	0.0087	CbGeAlD
Indomethacin—AKR1C3—decidua—uterine cancer	0.000427	0.00859	CbGeAlD
Indomethacin—GLO1—female gonad—uterine cancer	0.000423	0.00852	CbGeAlD
Indomethacin—PTGS1—artery—uterine cancer	0.000421	0.00849	CbGeAlD
Indomethacin—GLO1—vagina—uterine cancer	0.000421	0.00847	CbGeAlD
Indomethacin—AKR1C3—endometrium—uterine cancer	0.000405	0.00816	CbGeAlD
Indomethacin—PPARA—female reproductive system—uterine cancer	0.000404	0.00813	CbGeAlD
Indomethacin—PTGS2—artery—uterine cancer	0.000403	0.00811	CbGeAlD
Indomethacin—PLA2G2A—female gonad—uterine cancer	0.000393	0.00792	CbGeAlD
Indomethacin—AKR1C3—mammalian vulva—uterine cancer	0.000392	0.00789	CbGeAlD
Indomethacin—CXCL8—female gonad—uterine cancer	0.000389	0.00784	CbGeAlD
Indomethacin—SLC10A1—female reproductive system—uterine cancer	0.000388	0.00782	CbGeAlD
Indomethacin—CXCL8—vagina—uterine cancer	0.000387	0.0078	CbGeAlD
Indomethacin—UGT1A1—renal system—uterine cancer	0.000386	0.00778	CbGeAlD
Indomethacin—AKR1C3—uterus—uterine cancer	0.000373	0.00752	CbGeAlD
Indomethacin—PPARA—female gonad—uterine cancer	0.000367	0.0074	CbGeAlD
Indomethacin—UGT2B7—female reproductive system—uterine cancer	0.000364	0.00733	CbGeAlD
Indomethacin—SLC22A11—female reproductive system—uterine cancer	0.000355	0.00714	CbGeAlD
Indomethacin—PPARG—Teniposide—Etoposide—uterine cancer	0.000351	0.187	CbGdCrCtD
Indomethacin—SLCO1B1—renal system—uterine cancer	0.000321	0.00647	CbGeAlD
Indomethacin—ABCC3—decidua—uterine cancer	0.000311	0.00626	CbGeAlD
Indomethacin—AKR1C3—female gonad—uterine cancer	0.000305	0.00615	CbGeAlD
Indomethacin—ABCC3—renal system—uterine cancer	0.000305	0.00614	CbGeAlD
Indomethacin—AKR1C3—vagina—uterine cancer	0.000303	0.00611	CbGeAlD
Indomethacin—CES1—female reproductive system—uterine cancer	0.0003	0.00604	CbGeAlD
Indomethacin—PPARG—epithelium—uterine cancer	0.000299	0.00602	CbGeAlD
Indomethacin—ABCC1—myometrium—uterine cancer	0.000295	0.00594	CbGeAlD
Indomethacin—PPARG—smooth muscle tissue—uterine cancer	0.000288	0.0058	CbGeAlD
Indomethacin—PPARG—decidua—uterine cancer	0.000282	0.00569	CbGeAlD
Indomethacin—PPARG—renal system—uterine cancer	0.000277	0.00558	CbGeAlD
Indomethacin—CES1—female gonad—uterine cancer	0.000273	0.00549	CbGeAlD
Indomethacin—GLO1—lymph node—uterine cancer	0.000272	0.00548	CbGeAlD
Indomethacin—SLCO1A2—renal system—uterine cancer	0.000262	0.00527	CbGeAlD
Indomethacin—PPARG—mammalian vulva—uterine cancer	0.000259	0.00522	CbGeAlD
Indomethacin—SLCO1B1—female reproductive system—uterine cancer	0.000257	0.00519	CbGeAlD
Indomethacin—PLA2G2A—lymph node—uterine cancer	0.000253	0.00509	CbGeAlD
Indomethacin—ABCC4—renal system—uterine cancer	0.000252	0.00507	CbGeAlD
Indomethacin—CXCL8—lymph node—uterine cancer	0.00025	0.00504	CbGeAlD
Indomethacin—SLC22A8—renal system—uterine cancer	0.00025	0.00503	CbGeAlD
Indomethacin—PPARG—uterus—uterine cancer	0.000247	0.00497	CbGeAlD
Indomethacin—ABCC3—female reproductive system—uterine cancer	0.000244	0.00492	CbGeAlD
Indomethacin—ABCC2—renal system—uterine cancer	0.000244	0.00491	CbGeAlD
Indomethacin—PPARA—lymph node—uterine cancer	0.000236	0.00476	CbGeAlD
Indomethacin—ABCC1—uterine cervix—uterine cancer	0.000229	0.00462	CbGeAlD
Indomethacin—ABCC4—uterus—uterine cancer	0.000224	0.00452	CbGeAlD
Indomethacin—ABCC3—female gonad—uterine cancer	0.000222	0.00448	CbGeAlD
Indomethacin—PPARG—female reproductive system—uterine cancer	0.000222	0.00447	CbGeAlD
Indomethacin—ABCC1—decidua—uterine cancer	0.000219	0.0044	CbGeAlD
Indomethacin—ABCC1—endometrium—uterine cancer	0.000208	0.00418	CbGeAlD
Indomethacin—PPARG—female gonad—uterine cancer	0.000202	0.00407	CbGeAlD
Indomethacin—ABCC4—female reproductive system—uterine cancer	0.000202	0.00406	CbGeAlD
Indomethacin—PPARG—vagina—uterine cancer	0.000201	0.00404	CbGeAlD
Indomethacin—ABCC1—mammalian vulva—uterine cancer	0.000201	0.00404	CbGeAlD
Indomethacin—AKR1C3—lymph node—uterine cancer	0.000196	0.00395	CbGeAlD
Indomethacin—ABCC2—female reproductive system—uterine cancer	0.000195	0.00393	CbGeAlD
Indomethacin—PTGS2—myometrium—uterine cancer	0.000195	0.00392	CbGeAlD
Indomethacin—ABCC1—uterus—uterine cancer	0.000191	0.00385	CbGeAlD
Indomethacin—ABCC4—female gonad—uterine cancer	0.000183	0.0037	CbGeAlD
Indomethacin—CES1—lymph node—uterine cancer	0.000175	0.00353	CbGeAlD
Indomethacin—PTGS1—epithelium—uterine cancer	0.00016	0.00322	CbGeAlD
Indomethacin—PTGS1—uterine cervix—uterine cancer	0.000158	0.00319	CbGeAlD
Indomethacin—ABCC1—female gonad—uterine cancer	0.000156	0.00315	CbGeAlD
Indomethacin—ABCC1—vagina—uterine cancer	0.000156	0.00313	CbGeAlD
Indomethacin—PTGS1—smooth muscle tissue—uterine cancer	0.000154	0.0031	CbGeAlD
Indomethacin—PTGS2—epithelium—uterine cancer	0.000153	0.00308	CbGeAlD
Indomethacin—CYP2C19—vagina—uterine cancer	0.000152	0.00306	CbGeAlD
Indomethacin—PTGS2—uterine cervix—uterine cancer	0.000151	0.00305	CbGeAlD
Indomethacin—PTGS1—renal system—uterine cancer	0.000148	0.00299	CbGeAlD
Indomethacin—PTGS2—smooth muscle tissue—uterine cancer	0.000147	0.00296	CbGeAlD
Indomethacin—PTGS1—endometrium—uterine cancer	0.000143	0.00289	CbGeAlD
Indomethacin—ABCC3—lymph node—uterine cancer	0.000143	0.00288	CbGeAlD
Indomethacin—PTGS2—renal system—uterine cancer	0.000142	0.00285	CbGeAlD
Indomethacin—PTGS1—mammalian vulva—uterine cancer	0.000139	0.00279	CbGeAlD
Indomethacin—PTGS2—endometrium—uterine cancer	0.000137	0.00276	CbGeAlD
Indomethacin—PTGS1—uterus—uterine cancer	0.000132	0.00266	CbGeAlD
Indomethacin—CYP2C9—female reproductive system—uterine cancer	0.00013	0.00262	CbGeAlD
Indomethacin—PPARG—lymph node—uterine cancer	0.00013	0.00262	CbGeAlD
Indomethacin—PTGS2—uterus—uterine cancer	0.000126	0.00254	CbGeAlD
Indomethacin—ALB—lymph node—uterine cancer	0.000122	0.00245	CbGeAlD
Indomethacin—ABCB1—myometrium—uterine cancer	0.00012	0.00242	CbGeAlD
Indomethacin—PTGS1—female reproductive system—uterine cancer	0.000119	0.00239	CbGeAlD
Indomethacin—ABCC4—lymph node—uterine cancer	0.000118	0.00238	CbGeAlD
Indomethacin—ABCC2—lymph node—uterine cancer	0.000114	0.0023	CbGeAlD
Indomethacin—PTGS2—female reproductive system—uterine cancer	0.000113	0.00229	CbGeAlD
Indomethacin—PTGS1—female gonad—uterine cancer	0.000108	0.00218	CbGeAlD
Indomethacin—PTGS1—vagina—uterine cancer	0.000107	0.00216	CbGeAlD
Indomethacin—PTGS2—female gonad—uterine cancer	0.000103	0.00208	CbGeAlD
Indomethacin—PTGS2—vagina—uterine cancer	0.000103	0.00207	CbGeAlD
Indomethacin—ABCC1—lymph node—uterine cancer	0.000101	0.00203	CbGeAlD
Indomethacin—ABCB1—epithelium—uterine cancer	9.45e-05	0.0019	CbGeAlD
Indomethacin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	9.39e-05	0.00119	CcSEcCtD
Indomethacin—ABCB1—uterine cervix—uterine cancer	9.37e-05	0.00189	CbGeAlD
Indomethacin—Alopecia—Etoposide—uterine cancer	9.32e-05	0.00118	CcSEcCtD
Indomethacin—Vomiting—Progesterone—uterine cancer	9.31e-05	0.00118	CcSEcCtD
Indomethacin—Rash—Progesterone—uterine cancer	9.23e-05	0.00117	CcSEcCtD
Indomethacin—Dermatitis—Progesterone—uterine cancer	9.23e-05	0.00117	CcSEcCtD
Indomethacin—Headache—Progesterone—uterine cancer	9.18e-05	0.00116	CcSEcCtD
Indomethacin—Hot flush—Epirubicin—uterine cancer	9.13e-05	0.00116	CcSEcCtD
Indomethacin—Thrombophlebitis—Doxorubicin—uterine cancer	9.13e-05	0.00116	CcSEcCtD
Indomethacin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	9.08e-05	0.00115	CcSEcCtD
Indomethacin—Menopausal symptoms—Epirubicin—uterine cancer	9.06e-05	0.00115	CcSEcCtD
Indomethacin—Dermatitis exfoliative—Epirubicin—uterine cancer	9.06e-05	0.00115	CcSEcCtD
Indomethacin—Decreased appetite—Dactinomycin—uterine cancer	9e-05	0.00114	CcSEcCtD
Indomethacin—Renal impairment—Epirubicin—uterine cancer	8.98e-05	0.00114	CcSEcCtD
Indomethacin—ABCB1—decidua—uterine cancer	8.93e-05	0.0018	CbGeAlD
Indomethacin—Fatigue—Dactinomycin—uterine cancer	8.93e-05	0.00113	CcSEcCtD
Indomethacin—Purpura—Epirubicin—uterine cancer	8.87e-05	0.00112	CcSEcCtD
Indomethacin—Pain—Dactinomycin—uterine cancer	8.85e-05	0.00112	CcSEcCtD
Indomethacin—Vascular purpura—Doxorubicin—uterine cancer	8.84e-05	0.00112	CcSEcCtD
Indomethacin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	8.78e-05	0.00111	CcSEcCtD
Indomethacin—ABCB1—renal system—uterine cancer	8.76e-05	0.00177	CbGeAlD
Indomethacin—Eye pain—Doxorubicin—uterine cancer	8.76e-05	0.00111	CcSEcCtD
Indomethacin—Hypoglycaemia—Epirubicin—uterine cancer	8.76e-05	0.00111	CcSEcCtD
Indomethacin—Cardiac failure congestive—Doxorubicin—uterine cancer	8.72e-05	0.0011	CcSEcCtD
Indomethacin—Nausea—Progesterone—uterine cancer	8.7e-05	0.0011	CcSEcCtD
Indomethacin—Hyponatraemia—Epirubicin—uterine cancer	8.58e-05	0.00109	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	8.55e-05	0.00108	CcSEcCtD
Indomethacin—Osteoarthritis—Epirubicin—uterine cancer	8.55e-05	0.00108	CcSEcCtD
Indomethacin—Diplopia—Epirubicin—uterine cancer	8.55e-05	0.00108	CcSEcCtD
Indomethacin—Feeling abnormal—Dactinomycin—uterine cancer	8.53e-05	0.00108	CcSEcCtD
Indomethacin—Ill-defined disorder—Etoposide—uterine cancer	8.52e-05	0.00108	CcSEcCtD
Indomethacin—Anaemia—Etoposide—uterine cancer	8.49e-05	0.00107	CcSEcCtD
Indomethacin—ABCB1—endometrium—uterine cancer	8.47e-05	0.00171	CbGeAlD
Indomethacin—Gastrointestinal pain—Dactinomycin—uterine cancer	8.47e-05	0.00107	CcSEcCtD
Indomethacin—Hot flush—Doxorubicin—uterine cancer	8.45e-05	0.00107	CcSEcCtD
Indomethacin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	8.44e-05	0.00107	CcSEcCtD
Indomethacin—Dermatitis exfoliative—Doxorubicin—uterine cancer	8.38e-05	0.00106	CcSEcCtD
Indomethacin—Menopausal symptoms—Doxorubicin—uterine cancer	8.38e-05	0.00106	CcSEcCtD
Indomethacin—Rash—Medroxyprogesterone Acetate—uterine cancer	8.37e-05	0.00106	CcSEcCtD
Indomethacin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	8.36e-05	0.00106	CcSEcCtD
Indomethacin—Headache—Medroxyprogesterone Acetate—uterine cancer	8.31e-05	0.00105	CcSEcCtD
Indomethacin—Renal impairment—Doxorubicin—uterine cancer	8.31e-05	0.00105	CcSEcCtD
Indomethacin—Malaise—Etoposide—uterine cancer	8.28e-05	0.00105	CcSEcCtD
Indomethacin—Vertigo—Etoposide—uterine cancer	8.25e-05	0.00104	CcSEcCtD
Indomethacin—Leukopenia—Etoposide—uterine cancer	8.22e-05	0.00104	CcSEcCtD
Indomethacin—Purpura—Doxorubicin—uterine cancer	8.2e-05	0.00104	CcSEcCtD
Indomethacin—ABCB1—mammalian vulva—uterine cancer	8.2e-05	0.00165	CbGeAlD
Indomethacin—Abdominal pain—Dactinomycin—uterine cancer	8.18e-05	0.00104	CcSEcCtD
Indomethacin—Body temperature increased—Dactinomycin—uterine cancer	8.18e-05	0.00104	CcSEcCtD
Indomethacin—Hypoglycaemia—Doxorubicin—uterine cancer	8.1e-05	0.00103	CcSEcCtD
Indomethacin—Loss of consciousness—Etoposide—uterine cancer	8.07e-05	0.00102	CcSEcCtD
Indomethacin—Convulsion—Etoposide—uterine cancer	7.95e-05	0.00101	CcSEcCtD
Indomethacin—Hyponatraemia—Doxorubicin—uterine cancer	7.94e-05	0.001	CcSEcCtD
Indomethacin—Hypertension—Etoposide—uterine cancer	7.93e-05	0.001	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	7.91e-05	0.001	CcSEcCtD
Indomethacin—Diplopia—Doxorubicin—uterine cancer	7.91e-05	0.001	CcSEcCtD
Indomethacin—Osteoarthritis—Doxorubicin—uterine cancer	7.91e-05	0.001	CcSEcCtD
Indomethacin—Nausea—Medroxyprogesterone Acetate—uterine cancer	7.88e-05	0.000998	CcSEcCtD
Indomethacin—Chest pain—Etoposide—uterine cancer	7.82e-05	0.000989	CcSEcCtD
Indomethacin—ABCB1—uterus—uterine cancer	7.81e-05	0.00157	CbGeAlD
Indomethacin—Abdominal pain upper—Epirubicin—uterine cancer	7.8e-05	0.000988	CcSEcCtD
Indomethacin—Discomfort—Etoposide—uterine cancer	7.72e-05	0.000977	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Epirubicin—uterine cancer	7.69e-05	0.000974	CcSEcCtD
Indomethacin—Hypersensitivity—Dactinomycin—uterine cancer	7.63e-05	0.000965	CcSEcCtD
Indomethacin—Gastritis—Epirubicin—uterine cancer	7.56e-05	0.000957	CcSEcCtD
Indomethacin—Confusional state—Etoposide—uterine cancer	7.55e-05	0.000956	CcSEcCtD
Indomethacin—Muscular weakness—Epirubicin—uterine cancer	7.54e-05	0.000954	CcSEcCtD
Indomethacin—Anaphylactic shock—Etoposide—uterine cancer	7.49e-05	0.000948	CcSEcCtD
Indomethacin—Abdominal distension—Epirubicin—uterine cancer	7.44e-05	0.000941	CcSEcCtD
Indomethacin—Asthenia—Dactinomycin—uterine cancer	7.43e-05	0.00094	CcSEcCtD
Indomethacin—Asthma—Epirubicin—uterine cancer	7.39e-05	0.000935	CcSEcCtD
Indomethacin—Thrombocytopenia—Etoposide—uterine cancer	7.34e-05	0.000928	CcSEcCtD
Indomethacin—Tachycardia—Etoposide—uterine cancer	7.31e-05	0.000925	CcSEcCtD
Indomethacin—Hyperhidrosis—Etoposide—uterine cancer	7.24e-05	0.000917	CcSEcCtD
Indomethacin—Abdominal pain upper—Doxorubicin—uterine cancer	7.22e-05	0.000914	CcSEcCtD
Indomethacin—Anorexia—Etoposide—uterine cancer	7.14e-05	0.000904	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	7.12e-05	0.000901	CcSEcCtD
Indomethacin—Diarrhoea—Dactinomycin—uterine cancer	7.08e-05	0.000896	CcSEcCtD
Indomethacin—ABCB1—female reproductive system—uterine cancer	7.02e-05	0.00141	CbGeAlD
Indomethacin—Pancytopenia—Epirubicin—uterine cancer	7.01e-05	0.000888	CcSEcCtD
Indomethacin—Hypotension—Etoposide—uterine cancer	7e-05	0.000886	CcSEcCtD
Indomethacin—Gastritis—Doxorubicin—uterine cancer	7e-05	0.000886	CcSEcCtD
Indomethacin—Muscular weakness—Doxorubicin—uterine cancer	6.97e-05	0.000883	CcSEcCtD
Indomethacin—PTGS1—lymph node—uterine cancer	6.95e-05	0.0014	CbGeAlD
Indomethacin—Abdominal distension—Doxorubicin—uterine cancer	6.88e-05	0.000871	CcSEcCtD
Indomethacin—Asthma—Doxorubicin—uterine cancer	6.83e-05	0.000865	CcSEcCtD
Indomethacin—Pollakiuria—Epirubicin—uterine cancer	6.82e-05	0.000863	CcSEcCtD
Indomethacin—Paraesthesia—Etoposide—uterine cancer	6.73e-05	0.000851	CcSEcCtD
Indomethacin—Weight increased—Epirubicin—uterine cancer	6.72e-05	0.000851	CcSEcCtD
Indomethacin—Dyspnoea—Etoposide—uterine cancer	6.68e-05	0.000845	CcSEcCtD
Indomethacin—Hyperglycaemia—Epirubicin—uterine cancer	6.66e-05	0.000843	CcSEcCtD
Indomethacin—Somnolence—Etoposide—uterine cancer	6.66e-05	0.000843	CcSEcCtD
Indomethacin—PTGS2—lymph node—uterine cancer	6.64e-05	0.00134	CbGeAlD
Indomethacin—Drowsiness—Epirubicin—uterine cancer	6.59e-05	0.000833	CcSEcCtD
Indomethacin—Vomiting—Dactinomycin—uterine cancer	6.58e-05	0.000833	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	6.53e-05	0.000826	CcSEcCtD
Indomethacin—Rash—Dactinomycin—uterine cancer	6.53e-05	0.000826	CcSEcCtD
Indomethacin—Decreased appetite—Etoposide—uterine cancer	6.51e-05	0.000824	CcSEcCtD
Indomethacin—Pancytopenia—Doxorubicin—uterine cancer	6.49e-05	0.000821	CcSEcCtD
Indomethacin—Renal failure—Epirubicin—uterine cancer	6.47e-05	0.000819	CcSEcCtD
Indomethacin—Fatigue—Etoposide—uterine cancer	6.46e-05	0.000818	CcSEcCtD
Indomethacin—Neuropathy peripheral—Epirubicin—uterine cancer	6.45e-05	0.000817	CcSEcCtD
Indomethacin—Stomatitis—Epirubicin—uterine cancer	6.42e-05	0.000812	CcSEcCtD
Indomethacin—Jaundice—Epirubicin—uterine cancer	6.42e-05	0.000812	CcSEcCtD
Indomethacin—Pain—Etoposide—uterine cancer	6.41e-05	0.000811	CcSEcCtD
Indomethacin—Constipation—Etoposide—uterine cancer	6.41e-05	0.000811	CcSEcCtD
Indomethacin—ABCB1—female gonad—uterine cancer	6.39e-05	0.00129	CbGeAlD
Indomethacin—ABCB1—vagina—uterine cancer	6.35e-05	0.00128	CbGeAlD
Indomethacin—Sweating—Epirubicin—uterine cancer	6.31e-05	0.000799	CcSEcCtD
Indomethacin—Pollakiuria—Doxorubicin—uterine cancer	6.31e-05	0.000799	CcSEcCtD
Indomethacin—Haematuria—Epirubicin—uterine cancer	6.28e-05	0.000795	CcSEcCtD
Indomethacin—Weight increased—Doxorubicin—uterine cancer	6.22e-05	0.000787	CcSEcCtD
Indomethacin—Epistaxis—Epirubicin—uterine cancer	6.21e-05	0.000786	CcSEcCtD
Indomethacin—Feeling abnormal—Etoposide—uterine cancer	6.17e-05	0.000781	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—uterine cancer	6.16e-05	0.00078	CcSEcCtD
Indomethacin—Nausea—Dactinomycin—uterine cancer	6.15e-05	0.000778	CcSEcCtD
Indomethacin—Agranulocytosis—Epirubicin—uterine cancer	6.15e-05	0.000778	CcSEcCtD
Indomethacin—Gastrointestinal pain—Etoposide—uterine cancer	6.13e-05	0.000775	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—uterine cancer	6.09e-05	0.000771	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	6.04e-05	0.000764	CcSEcCtD
Indomethacin—Bradycardia—Epirubicin—uterine cancer	6.02e-05	0.000762	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—uterine cancer	5.99e-05	0.000758	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—uterine cancer	5.97e-05	0.000756	CcSEcCtD
Indomethacin—Urticaria—Etoposide—uterine cancer	5.95e-05	0.000753	CcSEcCtD
Indomethacin—Haemoglobin—Epirubicin—uterine cancer	5.94e-05	0.000752	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—uterine cancer	5.94e-05	0.000752	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—uterine cancer	5.94e-05	0.000752	CcSEcCtD
Indomethacin—Abdominal pain—Etoposide—uterine cancer	5.92e-05	0.00075	CcSEcCtD
Indomethacin—Body temperature increased—Etoposide—uterine cancer	5.92e-05	0.00075	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—uterine cancer	5.91e-05	0.000748	CcSEcCtD
Indomethacin—Hepatitis—Epirubicin—uterine cancer	5.91e-05	0.000748	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—uterine cancer	5.84e-05	0.000739	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—uterine cancer	5.81e-05	0.000735	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—uterine cancer	5.75e-05	0.000727	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—uterine cancer	5.69e-05	0.00072	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—uterine cancer	5.59e-05	0.000707	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—uterine cancer	5.57e-05	0.000705	CcSEcCtD
Indomethacin—Hypersensitivity—Etoposide—uterine cancer	5.52e-05	0.000699	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—uterine cancer	5.51e-05	0.000698	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—uterine cancer	5.5e-05	0.000696	CcSEcCtD
Indomethacin—Flushing—Epirubicin—uterine cancer	5.49e-05	0.000694	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—uterine cancer	5.47e-05	0.000692	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—uterine cancer	5.47e-05	0.000692	CcSEcCtD
Indomethacin—Asthenia—Etoposide—uterine cancer	5.38e-05	0.00068	CcSEcCtD
Indomethacin—Pruritus—Etoposide—uterine cancer	5.3e-05	0.000671	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—uterine cancer	5.28e-05	0.000668	CcSEcCtD
Indomethacin—Alopecia—Epirubicin—uterine cancer	5.22e-05	0.000661	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—uterine cancer	5.17e-05	0.000655	CcSEcCtD
Indomethacin—Erythema—Epirubicin—uterine cancer	5.15e-05	0.000651	CcSEcCtD
Indomethacin—Diarrhoea—Etoposide—uterine cancer	5.13e-05	0.000649	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—uterine cancer	5.1e-05	0.000645	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—uterine cancer	5.08e-05	0.000642	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—uterine cancer	5.07e-05	0.000642	CcSEcCtD
Indomethacin—Tension—Epirubicin—uterine cancer	5.05e-05	0.000639	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—uterine cancer	5e-05	0.000633	CcSEcCtD
Indomethacin—Dizziness—Etoposide—uterine cancer	4.95e-05	0.000627	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—uterine cancer	4.89e-05	0.000618	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—uterine cancer	4.85e-05	0.000614	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—uterine cancer	4.83e-05	0.000612	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—uterine cancer	4.77e-05	0.000604	CcSEcCtD
Indomethacin—Vomiting—Etoposide—uterine cancer	4.76e-05	0.000603	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—uterine cancer	4.76e-05	0.000603	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—uterine cancer	4.76e-05	0.000602	CcSEcCtD
Indomethacin—Rash—Etoposide—uterine cancer	4.72e-05	0.000598	CcSEcCtD
Indomethacin—Dermatitis—Etoposide—uterine cancer	4.72e-05	0.000597	CcSEcCtD
Indomethacin—Headache—Etoposide—uterine cancer	4.69e-05	0.000594	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—uterine cancer	4.69e-05	0.000594	CcSEcCtD
Indomethacin—Tension—Doxorubicin—uterine cancer	4.67e-05	0.000591	CcSEcCtD
Indomethacin—Malaise—Epirubicin—uterine cancer	4.64e-05	0.000587	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—uterine cancer	4.62e-05	0.000585	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—uterine cancer	4.62e-05	0.000585	CcSEcCtD
Indomethacin—Syncope—Epirubicin—uterine cancer	4.61e-05	0.000584	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—uterine cancer	4.61e-05	0.000583	CcSEcCtD
Indomethacin—Palpitations—Epirubicin—uterine cancer	4.55e-05	0.000576	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—uterine cancer	4.52e-05	0.000572	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—uterine cancer	4.49e-05	0.000568	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—uterine cancer	4.46e-05	0.000564	CcSEcCtD
Indomethacin—Nausea—Etoposide—uterine cancer	4.45e-05	0.000563	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—uterine cancer	4.44e-05	0.000562	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—uterine cancer	4.42e-05	0.000559	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—uterine cancer	4.4e-05	0.000557	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—uterine cancer	4.38e-05	0.000554	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—uterine cancer	4.37e-05	0.000553	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—uterine cancer	4.33e-05	0.000548	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—uterine cancer	4.29e-05	0.000543	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—uterine cancer	4.28e-05	0.000541	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—uterine cancer	4.27e-05	0.00054	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—uterine cancer	4.26e-05	0.000539	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—uterine cancer	4.23e-05	0.000536	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—uterine cancer	4.21e-05	0.000533	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—uterine cancer	4.2e-05	0.000532	CcSEcCtD
Indomethacin—Oedema—Epirubicin—uterine cancer	4.2e-05	0.000532	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—uterine cancer	4.18e-05	0.00053	CcSEcCtD
Indomethacin—Shock—Epirubicin—uterine cancer	4.13e-05	0.000523	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—uterine cancer	4.13e-05	0.000522	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—uterine cancer	4.11e-05	0.00052	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—uterine cancer	4.11e-05	0.00052	CcSEcCtD
Indomethacin—ABCB1—lymph node—uterine cancer	4.11e-05	0.000827	CbGeAlD
Indomethacin—Tachycardia—Epirubicin—uterine cancer	4.1e-05	0.000519	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—uterine cancer	4.06e-05	0.000514	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—uterine cancer	4.05e-05	0.000513	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—uterine cancer	4.04e-05	0.000511	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—uterine cancer	4.01e-05	0.000507	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—uterine cancer	4e-05	0.000507	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—uterine cancer	3.92e-05	0.000497	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—uterine cancer	3.92e-05	0.000496	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—uterine cancer	3.89e-05	0.000492	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—uterine cancer	3.89e-05	0.000492	CcSEcCtD
Indomethacin—Shock—Doxorubicin—uterine cancer	3.82e-05	0.000484	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—uterine cancer	3.8e-05	0.000482	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—uterine cancer	3.8e-05	0.000481	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—uterine cancer	3.79e-05	0.00048	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—uterine cancer	3.77e-05	0.000477	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—uterine cancer	3.76e-05	0.000475	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—uterine cancer	3.74e-05	0.000474	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—uterine cancer	3.73e-05	0.000473	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—uterine cancer	3.7e-05	0.000469	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—uterine cancer	3.7e-05	0.000468	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—uterine cancer	3.65e-05	0.000462	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—uterine cancer	3.63e-05	0.00046	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—uterine cancer	3.62e-05	0.000458	CcSEcCtD
Indomethacin—Constipation—Epirubicin—uterine cancer	3.59e-05	0.000455	CcSEcCtD
Indomethacin—Pain—Epirubicin—uterine cancer	3.59e-05	0.000455	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—uterine cancer	3.51e-05	0.000445	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—uterine cancer	3.49e-05	0.000442	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—uterine cancer	3.46e-05	0.000438	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—uterine cancer	3.46e-05	0.000438	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—uterine cancer	3.45e-05	0.000437	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—uterine cancer	3.43e-05	0.000435	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—uterine cancer	3.42e-05	0.000433	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—uterine cancer	3.38e-05	0.000428	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—uterine cancer	3.35e-05	0.000424	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—uterine cancer	3.34e-05	0.000422	CcSEcCtD
Indomethacin—Pain—Doxorubicin—uterine cancer	3.32e-05	0.000421	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—uterine cancer	3.32e-05	0.000421	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—uterine cancer	3.32e-05	0.00042	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—uterine cancer	3.32e-05	0.00042	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—uterine cancer	3.2e-05	0.000405	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—uterine cancer	3.18e-05	0.000402	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—uterine cancer	3.09e-05	0.000392	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—uterine cancer	3.09e-05	0.000391	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—uterine cancer	3.07e-05	0.000389	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—uterine cancer	3.07e-05	0.000389	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—uterine cancer	3.01e-05	0.000381	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—uterine cancer	2.97e-05	0.000376	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—uterine cancer	2.87e-05	0.000364	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—uterine cancer	2.86e-05	0.000362	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—uterine cancer	2.79e-05	0.000353	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—uterine cancer	2.78e-05	0.000351	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—uterine cancer	2.75e-05	0.000348	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—uterine cancer	2.67e-05	0.000338	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—uterine cancer	2.66e-05	0.000336	CcSEcCtD
Indomethacin—Rash—Epirubicin—uterine cancer	2.65e-05	0.000335	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—uterine cancer	2.65e-05	0.000335	CcSEcCtD
Indomethacin—Headache—Epirubicin—uterine cancer	2.63e-05	0.000333	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—uterine cancer	2.57e-05	0.000325	CcSEcCtD
Indomethacin—Nausea—Epirubicin—uterine cancer	2.49e-05	0.000316	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—uterine cancer	2.47e-05	0.000313	CcSEcCtD
Indomethacin—Rash—Doxorubicin—uterine cancer	2.45e-05	0.00031	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—uterine cancer	2.45e-05	0.00031	CcSEcCtD
Indomethacin—Headache—Doxorubicin—uterine cancer	2.43e-05	0.000308	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—uterine cancer	2.31e-05	0.000292	CcSEcCtD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.36e-06	0.000131	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—PIK3CA—uterine cancer	6.34e-06	0.000131	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTEN—uterine cancer	6.33e-06	0.000131	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—DCN—uterine cancer	6.33e-06	0.00013	CbGpPWpGaD
Indomethacin—ALB—Metabolism—POLD1—uterine cancer	6.32e-06	0.00013	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	6.31e-06	0.00013	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—MTHFR—uterine cancer	6.27e-06	0.000129	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—MTHFR—uterine cancer	6.27e-06	0.000129	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCL2—uterine cancer	6.24e-06	0.000129	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—STK11—uterine cancer	6.21e-06	0.000128	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CYP19A1—uterine cancer	6.21e-06	0.000128	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—KRAS—uterine cancer	6.21e-06	0.000128	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PTEN—uterine cancer	6.17e-06	0.000127	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.13e-06	0.000126	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—uterine cancer	6.13e-06	0.000126	CbGpPWpGaD
Indomethacin—ABCC1—Disease—FGFR2—uterine cancer	6.09e-06	0.000126	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.07e-06	0.000125	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EP300—uterine cancer	6.04e-06	0.000125	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FBXW7—uterine cancer	5.99e-06	0.000124	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP11A1—uterine cancer	5.96e-06	0.000123	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—MTHFR—uterine cancer	5.93e-06	0.000122	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKR1C1—uterine cancer	5.92e-06	0.000122	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—EP300—uterine cancer	5.88e-06	0.000121	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MTHFR—uterine cancer	5.86e-06	0.000121	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HRAS—uterine cancer	5.86e-06	0.000121	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.85e-06	0.000121	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.83e-06	0.00012	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—PIK3CA—uterine cancer	5.7e-06	0.000118	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.68e-06	0.000117	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—POLD1—uterine cancer	5.68e-06	0.000117	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NRAS—uterine cancer	5.65e-06	0.000117	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKR1C3—uterine cancer	5.63e-06	0.000116	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ESR1—uterine cancer	5.59e-06	0.000115	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.56e-06	0.000115	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—POLD1—uterine cancer	5.54e-06	0.000114	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—STK11—uterine cancer	5.52e-06	0.000114	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CYP19A1—uterine cancer	5.52e-06	0.000114	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.52e-06	0.000114	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—uterine cancer	5.52e-06	0.000114	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—MTHFR—uterine cancer	5.46e-06	0.000113	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—HRAS—uterine cancer	5.41e-06	0.000112	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	5.37e-06	0.000111	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKR1C1—uterine cancer	5.31e-06	0.000109	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTEN—uterine cancer	5.31e-06	0.000109	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—NRAS—uterine cancer	5.28e-06	0.000109	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—HRAS—uterine cancer	5.28e-06	0.000109	CbGpPWpGaD
Indomethacin—ALB—Metabolism—RRM2—uterine cancer	5.27e-06	0.000109	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.22e-06	0.000108	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ERBB2—uterine cancer	5.2e-06	0.000107	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.19e-06	0.000107	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKR1C1—uterine cancer	5.18e-06	0.000107	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—POLD1—uterine cancer	5.18e-06	0.000107	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—AKT1—uterine cancer	5.18e-06	0.000107	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PIK3CA—uterine cancer	5.12e-06	0.000106	CbGpPWpGaD
Indomethacin—ALB—Metabolism—DCN—uterine cancer	5.12e-06	0.000106	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—MTHFR—uterine cancer	5.09e-06	0.000105	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—MTHFR—uterine cancer	5.09e-06	0.000105	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—EP300—uterine cancer	5.06e-06	0.000104	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	5.01e-06	0.000103	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.94e-06	0.000102	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CXCL8—uterine cancer	4.93e-06	0.000102	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.93e-06	0.000102	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL2—uterine cancer	4.92e-06	0.000101	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—MTHFR—uterine cancer	4.91e-06	0.000101	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KRAS—uterine cancer	4.86e-06	0.0001	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKR1C1—uterine cancer	4.84e-06	9.98e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP11A1—uterine cancer	4.82e-06	9.94e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CDKN1B—uterine cancer	4.82e-06	9.93e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.81e-06	9.91e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—AKT1—uterine cancer	4.78e-06	9.85e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.77e-06	9.83e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—RRM2—uterine cancer	4.73e-06	9.76e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN2B—uterine cancer	4.69e-06	9.68e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—MTHFR—uterine cancer	4.67e-06	9.62e-05	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—AKT1—uterine cancer	4.66e-06	9.61e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—RRM2—uterine cancer	4.62e-06	9.53e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—PIK3CA—uterine cancer	4.6e-06	9.49e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTEN—uterine cancer	4.6e-06	9.48e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—DCN—uterine cancer	4.59e-06	9.47e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKR1C3—uterine cancer	4.55e-06	9.39e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CTNNB1—uterine cancer	4.55e-06	9.38e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—KRAS—uterine cancer	4.55e-06	9.38e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.49e-06	9.25e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—DCN—uterine cancer	4.48e-06	9.25e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PIK3CA—uterine cancer	4.47e-06	9.21e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PTEN—uterine cancer	4.44e-06	9.15e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—EP300—uterine cancer	4.39e-06	9.05e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—STK11—uterine cancer	4.39e-06	9.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP19A1—uterine cancer	4.39e-06	9.04e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PIK3CA—uterine cancer	4.35e-06	8.97e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP11A1—uterine cancer	4.33e-06	8.93e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.33e-06	8.92e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—RRM2—uterine cancer	4.32e-06	8.9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SMAD3—uterine cancer	4.29e-06	8.84e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EP300—uterine cancer	4.23e-06	8.72e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP11A1—uterine cancer	4.23e-06	8.71e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—DCN—uterine cancer	4.19e-06	8.64e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—uterine cancer	4.18e-06	8.62e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PIK3CA—uterine cancer	4.18e-06	8.62e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—MTHFR—uterine cancer	4.15e-06	8.56e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—uterine cancer	4.13e-06	8.53e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.12e-06	8.49e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.11e-06	8.48e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ERBB2—uterine cancer	4.1e-06	8.46e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	4.09e-06	8.43e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKR1C3—uterine cancer	4.09e-06	8.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGFR2—uterine cancer	4.09e-06	8.43e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.03e-06	8.3e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—uterine cancer	4.01e-06	8.26e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKR1C3—uterine cancer	3.99e-06	8.23e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NRAS—uterine cancer	3.96e-06	8.16e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP11A1—uterine cancer	3.95e-06	8.14e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTHFR—uterine cancer	3.93e-06	8.11e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.93e-06	8.09e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—uterine cancer	3.87e-06	7.97e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ERBB2—uterine cancer	3.82e-06	7.89e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1B—uterine cancer	3.8e-06	7.84e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—uterine cancer	3.76e-06	7.75e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PIK3CA—uterine cancer	3.74e-06	7.72e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKR1C3—uterine cancer	3.73e-06	7.69e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.66e-06	7.54e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—uterine cancer	3.65e-06	7.53e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CTNNB1—uterine cancer	3.59e-06	7.4e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—uterine cancer	3.56e-06	7.33e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—STK11—uterine cancer	3.55e-06	7.32e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP19A1—uterine cancer	3.55e-06	7.32e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1B—uterine cancer	3.54e-06	7.3e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTEN—uterine cancer	3.5e-06	7.22e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—EP300—uterine cancer	3.49e-06	7.19e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTEN—uterine cancer	3.49e-06	7.19e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTEN—uterine cancer	3.49e-06	7.19e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—uterine cancer	3.41e-06	7.04e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—uterine cancer	3.41e-06	7.03e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—uterine cancer	3.41e-06	7.02e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CTNNB1—uterine cancer	3.35e-06	6.9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EP300—uterine cancer	3.34e-06	6.88e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.33e-06	6.87e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—EP300—uterine cancer	3.32e-06	6.85e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—EP300—uterine cancer	3.32e-06	6.85e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—uterine cancer	3.3e-06	6.81e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—uterine cancer	3.3e-06	6.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—uterine cancer	3.3e-06	6.79e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—uterine cancer	3.26e-06	6.73e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—uterine cancer	3.26e-06	6.73e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—uterine cancer	3.25e-06	6.69e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—STK11—uterine cancer	3.18e-06	6.57e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP19A1—uterine cancer	3.18e-06	6.57e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.18e-06	6.55e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—uterine cancer	3.16e-06	6.52e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—EP300—uterine cancer	3.14e-06	6.48e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—uterine cancer	3.13e-06	6.45e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—uterine cancer	3.12e-06	6.44e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EP300—uterine cancer	3.11e-06	6.41e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—STK11—uterine cancer	3.11e-06	6.41e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP19A1—uterine cancer	3.11e-06	6.41e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—uterine cancer	3.06e-06	6.3e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—uterine cancer	3.04e-06	6.26e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—uterine cancer	3.03e-06	6.24e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.99e-06	6.16e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—uterine cancer	2.91e-06	6e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP19A1—uterine cancer	2.9e-06	5.99e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—STK11—uterine cancer	2.9e-06	5.99e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.9e-06	5.99e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—uterine cancer	2.9e-06	5.97e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—EP300—uterine cancer	2.89e-06	5.97e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.85e-06	5.88e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—uterine cancer	2.83e-06	5.84e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—uterine cancer	2.83e-06	5.84e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—uterine cancer	2.81e-06	5.79e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—uterine cancer	2.73e-06	5.63e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.73e-06	5.62e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—EP300—uterine cancer	2.7e-06	5.57e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—EP300—uterine cancer	2.7e-06	5.57e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—uterine cancer	2.69e-06	5.54e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—uterine cancer	2.67e-06	5.5e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—uterine cancer	2.65e-06	5.47e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—EP300—uterine cancer	2.6e-06	5.37e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.6e-06	5.36e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—uterine cancer	2.6e-06	5.35e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—uterine cancer	2.58e-06	5.32e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—uterine cancer	2.57e-06	5.29e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—uterine cancer	2.56e-06	5.27e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—uterine cancer	2.5e-06	5.16e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—uterine cancer	2.5e-06	5.15e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—EP300—uterine cancer	2.48e-06	5.1e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—uterine cancer	2.47e-06	5.09e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—uterine cancer	2.46e-06	5.07e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—uterine cancer	2.46e-06	5.07e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—uterine cancer	2.44e-06	5.04e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—uterine cancer	2.39e-06	4.93e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—uterine cancer	2.39e-06	4.92e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—uterine cancer	2.39e-06	4.92e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1B—uterine cancer	2.38e-06	4.9e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.35e-06	4.84e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—uterine cancer	2.34e-06	4.82e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—uterine cancer	2.33e-06	4.8e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—uterine cancer	2.31e-06	4.76e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—uterine cancer	2.3e-06	4.74e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—uterine cancer	2.28e-06	4.71e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CTNNB1—uterine cancer	2.25e-06	4.63e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—EP300—uterine cancer	2.2e-06	4.54e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—uterine cancer	2.19e-06	4.51e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—uterine cancer	2.18e-06	4.5e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—uterine cancer	2.14e-06	4.42e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—uterine cancer	2.13e-06	4.39e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.11e-06	4.35e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—uterine cancer	2.11e-06	4.35e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EP300—uterine cancer	2.09e-06	4.3e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—uterine cancer	2.02e-06	4.16e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—uterine cancer	2.01e-06	4.14e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—uterine cancer	2.01e-06	4.14e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—uterine cancer	2e-06	4.12e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—uterine cancer	2e-06	4.12e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—uterine cancer	1.95e-06	4.03e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—uterine cancer	1.93e-06	3.97e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.92e-06	3.97e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—uterine cancer	1.9e-06	3.92e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—uterine cancer	1.88e-06	3.88e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—uterine cancer	1.83e-06	3.78e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—uterine cancer	1.83e-06	3.78e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—uterine cancer	1.75e-06	3.61e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—EP300—uterine cancer	1.75e-06	3.6e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—uterine cancer	1.68e-06	3.47e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—uterine cancer	1.63e-06	3.37e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—uterine cancer	1.63e-06	3.37e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—uterine cancer	1.63e-06	3.36e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—uterine cancer	1.57e-06	3.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—uterine cancer	1.54e-06	3.18e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—uterine cancer	1.5e-06	3.08e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—uterine cancer	1.48e-06	3.06e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—uterine cancer	1.43e-06	2.95e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—EP300—uterine cancer	1.41e-06	2.92e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—uterine cancer	1.33e-06	2.75e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—uterine cancer	1.33e-06	2.74e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—uterine cancer	1.3e-06	2.68e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—uterine cancer	1.29e-06	2.67e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—EP300—uterine cancer	1.27e-06	2.62e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—uterine cancer	1.26e-06	2.6e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—EP300—uterine cancer	1.24e-06	2.56e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—uterine cancer	1.21e-06	2.5e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—EP300—uterine cancer	1.16e-06	2.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—uterine cancer	1.06e-06	2.18e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—uterine cancer	1.05e-06	2.16e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—uterine cancer	9.39e-07	1.94e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—uterine cancer	9.17e-07	1.89e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—uterine cancer	8.56e-07	1.77e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—uterine cancer	8.55e-07	1.76e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—uterine cancer	7.67e-07	1.58e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—uterine cancer	7.49e-07	1.54e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—uterine cancer	7e-07	1.44e-05	CbGpPWpGaD
